Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BDH IndustriesBOM:524828 +0.46%78 Days Payable is 74.27 as of Mar. 2026, which is 54% below its 10-year median of 160.55. GuruFocus rates BOM:524828 with a GF Score™ of 78/100 and a GF Value™ of ₹391.10 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 926 Drug Manufacturers companies, BDH Industries ranks worse than 53.46% on this metric.
The historical rank and industry rank for BDH Industries's Days Payable or its related term are showing as below:
BOM:524828'
s Days Payable Range Over the Past 10 Years
Min: 84.76 Med: 160.55 Max: 227.81
Current: 84.76
During the past 13 years, BDH Industries's highest Days Payable was 227.81. The lowest was 84.76. And the median was 160.55.
BOM:524828's Days Payable is ranked worse than 53.46% of 926
companies
in the Drug Manufacturers industry
Industry Median: 90.22
vs BOM:524828: 84.76
BDH Industries's Days Payable
declined
from Mar. 2025 (119.67) to Mar. 2026 (74.27).
It may suggest that BDH Industriesaccelerated paying its suppliers.
BDH Industries Days Payable Related Terms
BDH Industries Days Payable Historical Data
* Premium members only.
The historical data trend for BDH Industries's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BDH Industries's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BDH Industries Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BDH Industries's Days Payable distribution charts can be found below:
* The bar in red indicates where BDH Industries's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
BDH Industries's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BDH Industries (BOM:524828) has a Days Payable of 74.27 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BDH Industries and its competitors. This is 54% below median its historical median of 160.55. Over the past decade, BDH Industries' Days Payable has ranged from 84.76 to 227.81. According to the industry distribution chart, BDH Industries ranks #495 out of 926 companies in the Drug Manufacturers industry, placing it in the top 53.5%.
Is BDH Industries' Days Payable too high?
BDH Industries' current Days Payable of 74.27 is 54% below median its 10-year median of 160.55. Over the past 10 years, this metric has ranged from a low of 84.76 to a high of 227.81. The Drug Manufacturers industry median Days Payable is 90.22. BDH Industries' value of 74.27 is 17.7% below this industry median. Based on the distribution chart, BDH Industries ranks #495 out of 926 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, BDH Industries has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BDH Industries' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, BDH Industries ranks #495 out of 926 companies for Days Payable. This places BDH Industries in the lower half of its industry. The industry median Days Payable is 90.22. BDH Industries' value of 74.27 is 17.7% below this benchmark. Historically, BDH Industries' own Days Payable has ranged from 84.76 to 227.81 over the past decade. While the company's 10-year median is 160.55 vs. the industry median of 90.22, BDH Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.22, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BDH Industries's current Days Payable of 74.27 is 17.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BDH Industries and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BDH Industries's current Days Payable is 74.27, which is 54% below median its own 10-year median of 160.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BDH Industries stock overvalued right now?
Based on GuruFocus' analysis, BDH Industries (BOM:524828) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹391.10, compared to a current price of ₹581.35 — trading 48.6% above its estimated fair value. The current Days Payable is 74.27, which is 54% below median its 10-year median of 160.55 and 17.7% below the Drug Manufacturers industry median of 90.22. BDH Industries' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For BDH Industries (BOM:524828), the current Days Payable is 74.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BDH Industries (BOM:524828) Overvalued in 2026?
Based on GuruFocus' analysis, BDH Industries stock appears to be overvalued.
The current stock price of ₹581.35 is trading 48.6% above its estimated GF Value™ of ₹391.10.
GuruFocus considers BDH Industries to be Significantly Overvalued.
Key valuation signals for BOM:524828:
Days Payable: 74.27 (54% below median its 10-year median of 160.55)
GF Value™: ₹391.10 vs. price of ₹581.35 (48.6% above fair value)
Industry Position: 17.7% below the Drug Manufacturers median (#495 of 926)
No single metric tells the full story. See the BOM:524828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BDH Industries Ltd is an India based pharmaceutical company. It is engaged in the manufacturing of therapeutic formulations including various pharmaceuticals. The company has the following reportable segments; Pharmaceuticals and Renewable Energy. The majority of its revenue is generated from the Pharmaceuticals segment. The company's product portfolio encompasses therapeutic categories including antifungal, antibiotics, anticancer, antidiabetic, antidepressant, antiulcerant, antimalarials, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, psychotropic, and others.
78GF Score
Get the complete analysis for BOM:524828
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524828 has been successfully added to your 
